Skip to main content
Equibles

RDGT · Ridgetech Inc. · Metrics

Track RDGT — free

Use RDGT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RDGT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.83 +0.00 (+0.07%) At close · Oct 20
Rebalance outlook locked
Market Cap
$746,271
Shares
898,906
Volume · Oct 20 9938 Avg daily vol (3M) 1.84M

RDGT metrics

43 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.83
Market cap
$746,271

Price action

20 metrics
Price change (1W)
-3.4%
Price change (30D)
-7.7%
Price change (3M)
-43.5%
Price change (6M)
-60.4%
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
143.4%
Annualized volatility (3M)
141.0%
Beta
1.4
RSI (14D)
45.2
Price vs SMA 50
-5.5%
Price vs SMA 200
—
Avg volume (3M)
1.84M
Relative volume
0.0
Average dollar volume
$1.91M

Company

3 metrics
Sector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
898,906

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.0
reciprocal yield 5,464.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
3.6%
Operating margin
-1.4%
Trailing 12 months
Net margin
-0.9%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$45.96

Growth

11 metrics
Revenue growth YoY
+10.2%
Year over year
Net income growth YoY
-112.3%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
-106.2%
Shares change YoY
+96.6%
Year over year · more shares
Revenue CAGR (3Y)
+3.2%
Revenue CAGR (5Y)
-0.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-3.1%
Return on assets
-1.8%
Debt / equity
—
Current ratio
2.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$17.91M
Total assets
$69.03M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
5
13F filer change QoQ
0
Institutional ownership
14.2%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+6,645.5%
Holder tenure
1.1
Price vs estimated holder cost
—

Ownership (registered funds)

1 metrics
Index-fund ownership
0.0%

Short interest

3 metrics
Short interest
28.8%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1856084 CUSIP G2124G203 Visit website Investor relations